Patent 7943670 was granted and assigned to Eli Lilly and Company on May, 2011 by the United States Patent and Trademark Office.
Described is a soluble stable liquid formulation, process for preparing, and a method of using the soluble stable liquid formulation comprising ractopamine or a physiologically acceptable salt thereof, a liquid nonionic cosolvent, and water.